Fusion Antibodies plc is a early discovery partner located in Belfast, which develop and optimizes therapeutic and diagnostic antibodies. Working with early-stage Biotech\u2019s, Fusion\u2019s expertise, process frameworks, and development platforms, enables our clients to develop therapeutics within the most challenging modalities and diseases. Fusion guides them through early-stage antibody discovery, in the most efficient and effective way ensuring that the clients can achieve their goals<\/p>\n\n\n\n
Fusion Antibodies provides a broad range of partnering opportunities in antibody generation, development, production, characterisation, and optimisation. Our capabilities include antigen expression, antibody production, purification, sequencing, and antibody humanisation. Fusion’s proprietary CDRx\u00ae and RAMP\u00ae platforms provide our partners with antibodies that have a superior probability of reaching the patients.<\/p>\n\n\n\n